BRANFORD, Conn., March 2, 2011 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM), today reported financial results for the fourth quarter and full year 2010. For the year, FORE-SIGHT® tissue oximeter revenues increased 29% over the prior year to approximately $5.2 million. For the fourth quarter, worldwide FORE-SIGHT disposable sensor revenue increased 35% over the fourth quarter of 2009 on the strength of a 42% increase in domestic sensor revenue.
